Mitchel A. Kling - Concepedia

Author

Mitchel A. Kling

National Institute of Mental Health ORCID

Also Known As

Andrew Saykin, Kling, Mitchel A., M A Kling, M Kling, M. A. KLING, M. A. Kling, M. Kling, M.A. Kling, MITCHEL A. KLING, Maja Kling

134

Publications

11.3K

Citations

H-Index

131

Concepts

All Affiliations

National Institute of Mental Health National Institutes of Health University of Maryland, Baltimore University of Pennsylvania National Institute of Mental Health

About

Mitchel A. Kling is an author at National Institute of Mental Health specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	52	5.2K
2	Social Sciences	25	30	3.5K
3	Health Sciences	9	9	790
4	Public Health	1	1	15
5	Anesthesia	1	1	56

Mitchel A. Kling

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Responses to Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's Disease Philip W. Gold, D. Lynn Loriaux, Alec Roy, New England Journal of Medicine	1986	771
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone Ma‐Li Wong, Mitchel A. Kling, Peter J. Munson, Proceedings of the National Academy of Sciences	2000	579
Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia Leslie J. Crofford, Stanley R. Pillemer, Konstantine T. Kalogeras, Arthritis & Rheumatism	1994	511
Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. Michael D. De Bellis, George P. Chrousos, Lisa Dorn, The Journal of Clinical Endocrinology & Metabolism Pituitary HyporesponsivenessSexual DisordersMental HealthPsychologySocial Sciences	1994	488
Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study A. John Rush, Harold A. Sackeïm, Lauren B. Marangell, Biological Psychiatry Neuromodulation (Medicine)PsychiatryMood SymptomDepressionNaturalistic Study	2005	393
Major Depression Is Associated with Significant Diurnal Elevations in Plasma Interleukin-6 Levels, a Shift of Its Circadian Rhythm, and Loss of Physiological Complexity in Its Secretion: Clinical Implications Salvatore Alesci, Pedro E. Martinez, Sujata Kelkar, The Journal of Clinical Endocrinology & Metabolism	2005	373
A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression Mark S. George, A. John Rush, Lauren B. Marangell, Biological Psychiatry One-year ComparisonStimulation DevicePain DisordersPsychiatryNeuromodulation Therapies	2005	369
Treatment Outcomes in Depression: Comparison of Remote Treatment Through Telepsychiatry to In-Person Treatment Paul E. Ruskin, Michele Silver-Aylaian, Mitchel A. Kling, American Journal of Psychiatry	2004	353
Mood and cognitive side effects of interferon-alpha therapy. Alan Valentine, Christina A. Meyers, Mitchel A. Kling, PubMed	1998	318
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C Péter Hauser, Jaswinder Khosla, H Aurora, Molecular Psychiatry Hepatitis CPsychiatryViral HepatitisMood SymptomOpen-label Treatment	2002	313

Page 1